55 related articles for article (PubMed ID: 7664609)
1. [The study of relationship between c-erbB2 expression and cytoimmunology in ovarian carcinoma and its antisense regulation].
Jin Z; Zhang X; Feng Y
Zhonghua Fu Chan Ke Za Zhi; 1995 Apr; 30(4):222-4. PubMed ID: 7664609
[TBL] [Abstract][Full Text] [Related]
2. Resistance of human ovarian cancer cells to tumor necrosis factor and lymphokine-activated killer cells: correlation with expression of HER2/neu oncogenes.
Lichtenstein A; Berenson J; Gera JF; Waldburger K; Martinez-Maza O; Berek JS
Cancer Res; 1990 Nov; 50(22):7364-70. PubMed ID: 1977519
[TBL] [Abstract][Full Text] [Related]
3. [Effect of liposome-C-erbB2 antisense oligodeoxynucleotides on human ovarian cancer cells].
Shen M; Feng Y; Ge B
Zhonghua Fu Chan Ke Za Zhi; 1999 Aug; 34(8):485-7. PubMed ID: 11360601
[TBL] [Abstract][Full Text] [Related]
4. [Effects of recombinant human tumor necrosis factor on the development of ascitic tumor and expression of c-erbB2 in the nude mouse models of ovarian cancer].
Yin D; Zhang X; Feng Y
Zhonghua Fu Chan Ke Za Zhi; 1996 May; 31(5):291-2. PubMed ID: 9206183
[TBL] [Abstract][Full Text] [Related]
5. [Effect of antisense c-erbB2 on biologic behaviour and chemotherapeutic drug sensitivity in human ovarian cancer cells].
Wu L; Wu A; Jiang K
Zhonghua Fu Chan Ke Za Zhi; 1996 Mar; 31(3):169-72. PubMed ID: 8758793
[TBL] [Abstract][Full Text] [Related]
6. Growth inhibition of ovarian cancer cells induced by antisense IL-6 oligonucleotides.
Watson JM; Berek JS; Martínez-Maza O
Gynecol Oncol; 1993 Apr; 49(1):8-15. PubMed ID: 8482564
[TBL] [Abstract][Full Text] [Related]
7. Reduction of erbB2 gene product in mamma carcinoma cell lines by erbB2 mRNA-specific and tyrosine kinase consensus phosphorothioate antisense oligonucleotides.
Bertram J; Killian M; Brysch W; Schlingensiepen KH; Kneba M
Biochem Biophys Res Commun; 1994 Apr; 200(1):661-7. PubMed ID: 7909438
[TBL] [Abstract][Full Text] [Related]
8. Liposome-C-erbB2 antisense oligodoxynucleotides in human ovarian cancer cells.
Shen M; Feng Y; Ge B; Wu Z; Zhu M
Chin Med J (Engl); 2001 Jul; 114(7):735-7. PubMed ID: 11780339
[TBL] [Abstract][Full Text] [Related]
9. [Study of the amplification and expression of c-erbB2 oncogene in epithelial ovarian tumors].
Hou Y; Wang M; Liu W
Zhonghua Zhong Liu Za Zhi; 1996 Nov; 18(6):426-8. PubMed ID: 9387293
[TBL] [Abstract][Full Text] [Related]
10. [c-erbB2 gene amplification in human primary epithelial ovarian cancer and its clinical significance].
Yang H; Zhang G; Xu K
Zhonghua Zhong Liu Za Zhi; 1998 Sep; 20(5):367-70. PubMed ID: 10921034
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-alpha differentially modulates CD44 expression in ovarian cancer cells.
Muthukumaran N; Miletti-González KE; Ravindranath AK; Rodríguez-Rodríguez L
Mol Cancer Res; 2006 Aug; 4(8):511-20. PubMed ID: 16908592
[TBL] [Abstract][Full Text] [Related]
12. Loss of TNF-alpha-regulated COX-2 expression in ovarian cancer cells.
Yang WL; Roland IH; Godwin AK; Xu XX
Oncogene; 2005 Dec; 24(54):7991-8002. PubMed ID: 16044148
[TBL] [Abstract][Full Text] [Related]
13. Gamma-interferon reduces expression of the protooncogene c-erbB-2 in human ovarian carcinoma cells.
Marth C; Müller-Holzner E; Greiter E; Cronauer MV; Zeimet AG; Doppler W; Eibl B; Hynes NE; Daxenbichler G
Cancer Res; 1990 Nov; 50(21):7037-41. PubMed ID: 2119884
[TBL] [Abstract][Full Text] [Related]
14. Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A.
Yu D; Wolf JK; Scanlon M; Price JE; Hung MC
Cancer Res; 1993 Feb; 53(4):891-8. PubMed ID: 8094034
[TBL] [Abstract][Full Text] [Related]
15. Combination antigene therapy targeting c-myc and c-erbB(2) in the ovarian cancer COC(1) cell line.
Fei R; Shaoyang L
Gynecol Oncol; 2002 Apr; 85(1):40-4. PubMed ID: 11925118
[TBL] [Abstract][Full Text] [Related]
16. Profiling follicle stimulating hormone-induced gene expression changes in normal and malignant human ovarian surface epithelial cells.
Ho SM; Lau KM; Mok SC; Syed V
Oncogene; 2003 Jul; 22(27):4243-56. PubMed ID: 12833147
[TBL] [Abstract][Full Text] [Related]
17. Effect of TNF-alpha and IFN-alpha on the proliferation and cytotoxicity of lymphokine-activated killer cells in patients with bladder cancer.
Wang Z; Cheng Y; Zheng R; Qin D; Liu G
Chin Med J (Engl); 1997 Mar; 110(3):180-3. PubMed ID: 9594335
[TBL] [Abstract][Full Text] [Related]
18. [Study on transfer of interleukin-7 gene into ovarian carcinoma cells in vitro].
Cheng B; Chen HZ; Ye DF; Lu WG; Xie X
Zhonghua Fu Chan Ke Za Zhi; 2003 Apr; 38(4):199-202. PubMed ID: 12885363
[TBL] [Abstract][Full Text] [Related]
19. Combination of tumor necrosis factor alpha and interferon alpha induces apoptotic cell death through a c-myc-dependent pathway in p53 mutant H226br non-small-cell lung cancer cell line.
Yasuoka Y; Naomoto Y; Yamatsuji T; Takaoka M; Kimura M; Uetsuka H; Matsubara N; Fujiwara T; Gunduz M; Tanaka N; Haisa M
Exp Cell Res; 2001 Dec; 271(2):214-22. PubMed ID: 11716533
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-12 synergizes with interleukin-2 to generate lymphokine-activated killer activity in peripheral blood mononuclear cells cultured in ovarian cancer ascitic fluid.
Barton DP; Blanchard DK; Duan C; Roberts WS; Cavanagh D; DeCesare S; Djeu JY
J Soc Gynecol Investig; 1995; 2(6):762-71. PubMed ID: 9420887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
